Unveiling some mechanisms that trigger Parkinson’s

The loss of the brain’s ability to produce dopamine is the cause of Parkinson’s disease.

50 years ago levodopa was developed, which supplies the brain with the missing dopamine, and it is still the gold standard for treating Parkinson’s. In order to fight not only the symptoms but also the disease itself, to slow down or stop its progression, the mechanisms that bring the production of dopamine to a standstill must be recognised.

Researchers at the University of Dundee have discovered some of these mechanisms and are thus feeding hope for a novel treatment of the causes of Parkinson’s disease.

The DRIG Spring Conference 2018 is dedicated to this topic.

The event is aimed at anyone with an interest in Parkinson’s disease – patients, carers, healthcare professionals or anyone interested in learning more about the disease. Participation in the conference is free, but registration is still required.

In addition to the conference contributions of renowned scientists and experts, there will be an interaction session during which participants can exchange directly with scientists and professionals and thus stimulate further research.

Date: June 26, 15:30 – 19:00
Location: Invercarse Hotel, 371 Perth Road, Dundee, DD2 1PG

Programme

Time Topic Speaker
15:30 Registration and refreshments, Interaction Session
16:00 Opening by Marc van Grieten (MvG) and
Introduction of John Minhinick (JM) as chair of the conference
MvG
16:05 Introduction of Prof Ken Bowler
From Edinburgh to Dundee: Research Interest Groups – a success story
JM
Prof Ken Bowler
16:20 Introduction of MvG by JM
Perspective of a Person with Parkinson’s
JM
MvG
16:30 Introduction of Prof Dario Alessi
LRRK2 in Parkinson’s
Facilitated Q&A / discussion
JM
Prof Dario Alessi
17:10 Introduction of Dr. Esther Sammler
Bench to bedside Parkinson’s research
Facilitated Q&A / discussion
JM
Dr. Esther Sammler
17:30 Break and Interaction Session
18:10 Introduction of Dr. Miratul Muqit
Cells, energy control and Parkinson’s: the role of PINK1 and Parkin
Facilitated Q&A / discussion
JM
Dr. Miratul Muqit
18:30 Panel discussion and further Q&A
Panel: Ken Bowler, Dario Alessi, Esther Sammler and Miratul Muqit
JM
18:55 Conclusion and closing remarks MvG
19:00 End of Event

Please register for the event